Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Celgene slipped up repeatedly last year. So why did CEO Mark Alles get a raise?

fiercepharmaMarch 06, 2019

Tag: Celgene , slipped up , CEO Mark Alles

PharmaSources Customer Service